Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
|
Pre-Market Last Trade |
Last: $ 42.80 ▲ 0.53 (1.25%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| GlaxoSmithKline PLC | GSK | NYSE | Depository Receipt |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 42.27 | 0.00 | 0.00 | 0.00 | 42.27 | 04:17:02 |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 5 | 1,351 | 2,259,003 | 36.41 - 43.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:04:47 | formt | 180 | 42.80 | USD |
GlaxoSmithKline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | |
|---|---|---|---|---|---|
| 105.44B | 2.49B | 4.83B | 1.86 | 18.20 | 2.49B |
| Dividends Per Share | Dividend Yield | ||||
|---|---|---|---|---|---|
| 6.56M | 2.05 | 4.85% | 08/08/19 | - | - |
News GlaxoSmithKline
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
GSK Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0 | 0 | 0 | 0.0000 | - | - | - |
| 1 Month | 0 | 0 | 0 | 0.0000 | - | - | - |
| 3 Months | 0 | 0 | 0 | 0.0000 | - | - | - |
| 6 Months | 0 | 0 | 0 | 0.0000 | - | - | - |
| 1 Year | 0 | 0 | 0 | 0.0000 | - | - | - |
| 3 Years | 0 | 0 | 0 | 0.0000 | - | - | - |
| 5 Years | 0 | 0 | 0 | 0.0000 | - | - | - |
| In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. |
